RLT-Connect joins forces with Industry Leader to Fuel Cancer Treatment Donations
Oncidium Foundation and Telix Pharmaceuticals Collaborate to Enhance Access [...]
Oncidium Launches Global ‘RLT-Connect’ Platform
The Oncidium foundation is launching 'RLT-Connect', a revolutionary platform [...]
A major component to successfully establish radioligand therapy
Tackling the Last Mile: A major component to successfully establish [...]
SNMMI Abstract of the Year 2022
New research presented at the Society of Nuclear Medicine and [...]
Rare is Many
Do you know that there are 300 million people worldwide [...]
Estimate the anticipated benefit from Lutetium-177-DOTATATE
External Validation of a Clinical Score for Patients With Neuroendocrine [...]
Travel cards could help radiopharma patients avoid delays
April 29, 2020 -- Patients who undergo radiation treatment with lutetium-177 [...]
PSMA theranostic Lu-177-PSMA-617 approaches prime time in mCRPC
Urology Times Journal, Jason M. Broderick - April 15, 2021 [...]
Doctor, What is Neuroendocrine Cancer?
Waiting for a download is frustrating. Imagine waiting 5+ years [...]
How PRRT can Improve Care for Neuroendocrine Tumor Patients
Learn more about how Peptide Receptor Radionuclide Therapy (PRRT) can [...]